Point72 Asset Management »

Rapt Therapeutics shares owned by Point72 Asset Management

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Point72 Asset Management from 13F filings

Historical chart of Point72 Asset Management investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by Point72 Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by Point72 Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $319k 12k 25.79

More positions owned by Point72 Asset Management

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Arista Networks Com Shs (ANET)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Amazon (AMZN)
Credo Technology Group Holdi Ordinary Shares (CRDO)
Biogen Idec (BIIB)
Meta Platforms Cl A (META)
Teradyne (TER)
Advanced Micro Devices (AMD)
Asml Holding N V N Y Registry Shs (ASML)
Broadcom (AVGO)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Airbnb Com Cl A (ABNB)

View all positions for Point72 Asset Management

Top funds holding Rapt Therapeutics

TCG Crossover Management
Foresite Capital Management VI
Rtw Investments
OrbiMed Advisors
Ikarian Capital
Boone Capital Management
Deep Track Capital
Vanguard Group
Nantahala Capital Management
Siren
Redmile Group
Soleus Capital Management
ADAR1 Capital Management
Fcpm Iii Services B.v.
Boothbay Fund Management

View all funds holding Rapt Therapeutics